Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

2243639-98-5Atorvastatin Impurity 138 Calcium Salt

● Auf Lager

Katalog-Nr.::	VE0026810
CAS-Nr.::	2243639-98-5
Summenformel::	C66H68CaF2N4O10
Molare Masse::	1155.34 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 2243639-98-5

Parent drug

Atorvastatin

IUPAC-Name

calcium bis((3R,5R)-7-[2-(2-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate)

SMILES

O=C([O-])C[C@H](O)C[C@H](O)CCN1C(C(C)C)=C(C(NC2=CC=CC=C2)=O)C(C3=CC=CC=C3)=C1C4=CC=CC=C4F.O=C([O-])C[C@@H](O)C[C@@H](O)CCN5C(C(C)C)=C(C(NC6=CC=CC=C6)=O)C(C7=CC=CC=C7)=C5C8=CC=CC=C8F.[Ca+2]

InChI

InChI=1S/2C33H35FN2O5.Ca/c2*1-21(2)31-30(33(41)35-23-13-7-4-8-14-23)29(22-11-5-3-6-12-22)32(26-15-9-10-16-27(26)34)36(31)18-17-24(37)19-25(38)20-28(39)40;/h2*3-16,21,24-25,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40);/q;;+2/p-2/t2*24-,25-;/m10./s1

Beschreibung

Atorvastatin Impurity 138 Calcium Salt (CAS 2243639-98-5) is a degradation-related byproduct encountered during synthesis and storage of atorvastatin active pharmaceutical ingredient, presenting as a calcium-coordinated ionic species with altered solubility and chromatographic retention. Proper identification by LC-MS, NMR and HRMS is critical for structural confirmation, while method development must address peak tailing and variable response factors due to salt formation. Risk assessment focuses on formation pathways, stability under humid and basic conditions, and potential impact on assay and purity specifications. Controlled manufacturing parameters, targeted purification and validated analytical limits support regulatory compliance and quality assurance for atorvastatin drug substance.